{
     "PMID": "22150282",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20120419",
     "LR": "20131121",
     "IS": "1608-3040 (Electronic) 0006-2979 (Linking)",
     "VI": "76",
     "IP": "12",
     "DP": "2011 Dec",
     "TI": "In vivo injected mitochondria-targeted plastoquinone antioxidant SkQR1 prevents beta-amyloid-induced decay of long-term potentiation in rat hippocampal slices.",
     "PG": "1367-70",
     "LID": "10.1134/S0006297911120108 [doi]",
     "AB": "Addition of 200 nM beta-amyloid 1-42 (Abeta) to a rat hippocampal slice impairs the induction of a long-term post-tetanic potentiation (LTP) of population spike (PS) in pyramidal neurons of the CA1 field of hippocampus. Intraperitoneal injection into the rat of the mitochondria-targeted plastoquinone derivative SkQR1 (1 micromol/kg of weight given 24 h before the slices were made) abolishes the deleterious effect of Abeta on LTP. These data demonstrate that SkQR1 therapy is able to compensate the Abeta-induced impairments of long-term synaptic plasticity in the hippocampus, which are the main cause of loss of memory and other cognitive functions associated with Alzheimer's disease.",
     "CI": [
          "(c) Pleiades Publishing, Ltd., 2011."
     ],
     "FAU": [
          "Kapay, N A",
          "Isaev, N K",
          "Stelmashook, E V",
          "Popova, O V",
          "Zorov, D B",
          "Skrebitsky, V G",
          "Skulachev, V P"
     ],
     "AU": [
          "Kapay NA",
          "Isaev NK",
          "Stelmashook EV",
          "Popova OV",
          "Zorov DB",
          "Skrebitsky VG",
          "Skulachev VP"
     ],
     "AD": "Department of Brain Research, Research Center of Neurology, Russian Academy of Medical Sciences, Pereulok Obukha 5, 105064 Moscow, Russia. kapayn@gmail.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "United States",
     "TA": "Biochemistry (Mosc)",
     "JT": "Biochemistry. Biokhimiia",
     "JID": "0376536",
     "RN": [
          "0 (10-(6'-plastoquinonyl) decylrhodamine 19)",
          "0 (Amyloid beta-Peptides)",
          "0 (Antioxidants)",
          "0 (Rhodamines)",
          "OAC30J69CN (Plastoquinone)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/drug therapy/metabolism/*physiopathology",
          "Amyloid beta-Peptides/*toxicity",
          "Animals",
          "Antioxidants/*administration & dosage",
          "CA1 Region, Hippocampal/cytology/*drug effects/physiopathology",
          "Disease Models, Animal",
          "Humans",
          "Long-Term Potentiation/*drug effects",
          "Male",
          "Mitochondria/*drug effects/metabolism",
          "Neurons/drug effects/physiology",
          "Plastoquinone/administration & dosage/*analogs & derivatives",
          "Rats",
          "Rats, Wistar",
          "Rhodamines/*administration & dosage"
     ],
     "EDAT": "2011/12/14 06:00",
     "MHDA": "2012/04/20 06:00",
     "CRDT": [
          "2011/12/14 06:00"
     ],
     "PHST": [
          "2011/12/14 06:00 [entrez]",
          "2011/12/14 06:00 [pubmed]",
          "2012/04/20 06:00 [medline]"
     ],
     "AID": [
          "BCM76121695 [pii]",
          "10.1134/S0006297911120108 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Biochemistry (Mosc). 2011 Dec;76(12):1367-70. doi: 10.1134/S0006297911120108.",
     "term": "hippocampus"
}